₹ 548.20
-8.20 (-1.47%)
C
Concord Biotech
₹ 548.20
Concord Biotech Fundamentals
Company Valuation
Market Cap (₹ Cr.)
11,470
PE Ratio
41.70
PB Ratio
5.61
Dividend Yield
1.36%
ROE
12.86%
ROCE
16.70%
Book Value (₹)
99.21
Face Value (₹)
1.00
Analyse CONCORDBIO with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Nov 2026 |
|---|---|---|---|---|---|
| Promoters | 44.08% | 44.08% | 44.08% | 44.09% | 44.09% |
| Domestic Institutional Investors (DII) | 9.58% | 9.22% | 9.36% | 10.95% | 11.01% |
| Foreign Institutional Investors (FII) | 7.58% | 7.80% | 7.52% | 7.28% | 7.34% |
| Public Investors | 8.11% | 8.09% | 8.23% | 8.81% | 8.78% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
CONCORDBIO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
543960
NSE Scrip Name
CONCORDBIO
ISIN
INE338H01029
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






